Fda & health articles
-
This Week at FDA: FDA's final LDT rule nears, Cardinal Health warning letter, and more
Welcome to another installment of This Week at FDA, your weekly source for updates @ big and small @ on FDA, drug, and medical device regulation, and what we@re reading from around the web. This week, we learned that FDA@s final rule on laboratory developed tests (LDTs) may soon see the light of day. @
-
Apple Watch feature becomes first digital health tech to receive this FDA approval
The Apple Watch AFib feature has already been credited with saving lives.
-
Pfizer reportedly withheld presence of cancer-linked DNA in COVID jabs from FDA, Health Canada
According to information released by the Epoch Times, Pfizer purposefully failed to advise drug regulators, including Health Canada, the U.S. FDA and the European Medicines Agency, that the cancer-linked SV40 DNA enhancer was present in their experimental COVID shot.